The overexpression of IDO1/TDO2 and the consequent accumulation of KYN suppress anti-tumor immunity by promoting the differentiation of Tregs and MDSCs, which in turn, inhibit the activity of effector CD8+T cells and NK cells (Figure 1A). This evidence concerns the gene IDO1 and neoplasm.